These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22571571)

  • 1. TNF-α inhibitor (adalimumab) induced psoriasis: a case report.
    Al-Mutairi A; Elkashlan M; Al-Fayed HM; Swayed M
    Australas J Dermatol; 2012 May; 53(2):157. PubMed ID: 22571571
    [No Abstract]   [Full Text] [Related]  

  • 2. Adalimumab-induced psoriasis in a patient with Crohn's disease.
    Korkmaz U; Duman AE; Dindar G; Yilmaz H; Dursun IH; Celebi A; Senturk O; Hulagu S
    Indian J Gastroenterol; 2013 Mar; 32(2):135-6. PubMed ID: 23151897
    [No Abstract]   [Full Text] [Related]  

  • 3. First case report of adalimumab-induced psoriasis in Crohn's disease.
    Harris MD; Richards R
    Am J Gastroenterol; 2009 Mar; 104(3):792-3. PubMed ID: 19262532
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].
    Sansó Sureda A; Rocamora Durán V; Sapiña Camaró A; Royo Escosa V; Bosque López MJ
    Gastroenterol Hepatol; 2011 Oct; 34(8):546-50. PubMed ID: 21665330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature.
    Cullen G; Kroshinsky D; Cheifetz AS; Korzenik JR
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1318-27. PubMed ID: 21957906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
    Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
    J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasiform dermatitis in a non-psoriatic patient treated with adalimumab.
    Tammaro A; Persechino S; Abruzzese C; Narcisi A; Cortesi G; Parisella FR; Laganà B
    Int J Immunopathol Pharmacol; 2012; 25(2):499-501. PubMed ID: 22697082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease].
    Monteagudo Sánchez B; Cabanillas M; Ortiz-Marin S; Gallego-Ojea JC
    Gastroenterol Hepatol; 2009 Mar; 32(3):175-6. PubMed ID: 19233516
    [No Abstract]   [Full Text] [Related]  

  • 9. Generalized pustular psoriasis-like eruptions induced after the first use of adalimumab in the treatment of psoriatic arthritis.
    Kimura U; Kinoshita A; Haruna K; Mizuno Y; Sekigawa I; Takamori K; Suga Y
    J Dermatol; 2012 Mar; 39(3):286-7. PubMed ID: 21957978
    [No Abstract]   [Full Text] [Related]  

  • 10. New-onset psoriasis associated with adalimumab: a report of two cases.
    Glenn CJ; Kobraei KB; Russo JJ
    Dermatol Online J; 2011 Sep; 17(9):15. PubMed ID: 21971280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: case report and review.
    Puig L; Morales-Múnera CE; López-Ferrer A; Geli C
    Dermatology; 2012; 225(1):14-7. PubMed ID: 22890275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literature.
    Osório F; Magro F; Lisboa C; Lopes S; Macedo G; Bettencourt H; Azevedo F; Magina S
    Dermatology; 2012; 225(2):163-7. PubMed ID: 23052429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pityriasis amiantacea: a distinctive presentation of psoriasis associated with tumour necrosis factor-α inhibitor therapy.
    Ettler J; Wetter DA; Pittelkow MR
    Clin Exp Dermatol; 2012 Aug; 37(6):639-41. PubMed ID: 22300412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis.
    Marcella S; Welsh B; Foley P
    Australas J Dermatol; 2011 Aug; 52(3):e8-11. PubMed ID: 21834808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palmoplantar pustulosis with fulminant dystrophic 20-nail psoriasis in a patient receiving adalimumab therapy.
    Mishra V; Daniel RC; Elmets CA; Levin A; Elewski BE
    J Drugs Dermatol; 2013 Jan; 12(1):16-7. PubMed ID: 23377322
    [No Abstract]   [Full Text] [Related]  

  • 16. [Level of adalimumab and its antibody titers define the effectiveness of the biological (anticytokine) therapy in Crohn's disease].
    Lazebnik LB; Sagynbaeva VÉ
    Eksp Klin Gastroenterol; 2013; (7):18-22. PubMed ID: 24772870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flexural psoriasis induced by infliximab and adalimumab in a patient with Crohn's disease].
    Avila Alvarez A; García-Alonso L; Solar Boga A; García-Silva J
    An Pediatr (Barc); 2009 Mar; 70(3):278-81. PubMed ID: 19409245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five cases of anti-tumor necrosis factor alpha-induced psoriasis presenting with severe scalp involvement in children.
    Perman MJ; Lovell DJ; Denson LA; Farrell MK; Lucky AW
    Pediatr Dermatol; 2012; 29(4):454-9. PubMed ID: 21995665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE.
    Ortonne JP; Chimenti S; Reich K; Gniadecki R; Sprøgel P; Unnebrink K; Kupper H; Goldblum O; Thaçi D
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1012-20. PubMed ID: 21214631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmoplantar pustulosis by adalimumab in a patient with Crohn disease.
    Ortiz Salvador JM; Cubells Sánchez L; Subiabre Ferrer D
    Med Clin (Barc); 2016 Dec; 147(12):565. PubMed ID: 27431884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.